CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- 4 Grant or award Director acquired 3,997 shares (grant or award)
- 4 Grant or award Director acquired 3,997 shares (grant or award)
- 8-K Event Results of operations
- 4 Planned sale Chief Product Officer sold 2,200 shares at $30.10 ($66,221)
- 4 Planned sale Chief Product Officer sold 7,800 shares at an average $29.61 ($230,950)
- 4 Planned sale Chief Financial Officer sold 20,000 shares at $29.53 ($590,680)
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Product Officer sold 1,063 shares at $29.34 ($31,184)
- 4 Open-market sale Chief Financial Officer sold 1,427 shares at $29.34 ($41,862)
- 4 Open-market sale President & CEO sold 3,278 shares at $29.34 ($96,163)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 1,406 shares at an average $29.55 ($41,543)
- 4 Planned sale Director sold 1,406 shares at an average $29.55 ($41,552)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 7 of 15 · 290 filings